Physician profile
John T Duell
NPI 1598994261
$2,760.20
in general payments reported to CMS, 2019-2025
19 companies · $981 in 2025
The $981 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.92 · 2021: $17.15 · 2022: $309 · 2023: $808 · 2024: $554 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929 · Travel and Lodging: $344 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.01 |
| Travel and Lodging | $343.51 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $931.34 | 2022-2023 | Selectsecure, Micra |
| Novo Nordisk INC | $261.23 | 2024-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $248.73 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $217.68 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.04 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $157.35 | 2021-2025 | |
| Abbott Laboratories | $112.76 | 2025 | Amplatzer Amulet |
| Bridgebio Pharma, INC. | $105.58 | 2025 | Attruby |
| Amgen INC. | $104.27 | 2024-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $102.51 | 2024-2025 | |
| Medtronic Vascular, INC. | $68.43 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $65.55 | 2024-2025 | Opsumit, Opsynvi |
| Merck Sharp & Dohme LLC | $37.38 | 2024-2025 | Verquvo |
| Baxter Healthcare | $30.78 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $27.50 | 2025 | Lm Undivided |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $26.33 | 2025 | |
| Alnylam Pharmaceuticals INC. | $25.00 | 2025 | Onpattro |
| Boston Scientific Corporation | $23.49 | 2019 | |
| Scpharmaceuticals INC. | $16.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Duell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.